About - Resero Analytics

ABOUT US

Who is Resero Analytics?

Resero Analytics makes drug development software that helps scientists analyze, interpret, and communicate their study results

David Watson, Ph.D.

Founder & CEO

Resero Analytics is building the software Dave wished he had in Pharma where he helped develop small molecules, peptides, and antibodies for infectious diseases, diabetes, and oncology.

Anil Gunturu

CTO

Responsible for guiding technology strategy and system architecture for Resero’s innovative products, while also contributing to the overall vision and long-term strategy.

C. Edwin Garner, Ph.D.

VP of Modeling & Simulation

C. Edwin Garner, Ph.D. has 25 years of experience in the drug discovery and development arena from startups to large pharma (DuPont/Merck, Schering-Plough, AstraZeneca). He is responsible for guiding scientific strategy and implementation of Resero’s innovative modeling products and services. He is an expert in classical pharmacokinetic and PBPK modeling/simulation based translation of preclinical PK and PD to the clinical environment.

Andrew Vick, Ph.D.

Advisor

Responsible for corporate development, leveraging 28 years of experience in biotech and in the pharmaceutical industry across both innovator and supplier roles. His expertise spans toxicology, nonclinical and clinical pharmacology, and drug disposition, helping drive growth and strategic partnerships.

Taylor Scott

Product Manager

Responsible for client relationships by demonstrating our products, coordinating efficient deployments, and refining product designs to meet client needs.

Chris Campetti

Software Engineer

Responsible for frontend technologies, like React, and collaborating with the backend team to assure our technology stack is performant and accurate to the functional design.

Sunny Arora

Senior Backend and DevOps Engineer

Responsible for designing and optimizing scalable backend system, automating workflows, and managing infrastructure to ensure system reliability and delivery of efficient solutions through robust CI/CD practices.

Angelo Dalde

QA Tester

Responsible for designing the manual test suite for software releases to ensure compliance with the requirement specifications and high quality standards.

Satvik Sharma

Software Engineer

Responsible for designing and coding the TurboProposal user interface, ensuring a seamless and intuitive user experience.

Andy Dahlem

Business Advisor

Andy served as VP of R&D at Eli Lilly, with numerous responsibilities including for Toxicology and Drug Disposition, R&D Strategy, Due Diligence, and Competitive Intelligence. He also served as Chief, Division of Clinical Pharmacology, at the Indiana University School of Medicine.